Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
13.52
0.00 (0.00%)
At close: Feb 21, 2025, 4:00 PM
13.62
+0.10 (0.74%)
After-hours: Feb 21, 2025, 5:24 PM EST
Sotera Health Company Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Sotera Health Company stock have an average target of 16.5, with a low estimate of 13 and a high estimate of 20. The average target predicts an increase of 22.04% from the current stock price of 13.52.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sotera Health Company stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +25.74% | Feb 18, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +25.74% | Nov 21, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +47.93% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +25.74% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +25.74% | Aug 6, 2024 |
Financial Forecast
Revenue This Year
1.11B
from 1.05B
Increased by 5.98%
Revenue Next Year
1.17B
from 1.11B
Increased by 5.31%
EPS This Year
0.70
from 0.18
Increased by 288.35%
EPS Next Year
0.79
from 0.70
Increased by 13.61%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.2B | 1.2B | 1.3B | |
| Avg | 1.1B | 1.2B | 1.2B | |
| Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 10.7% | 10.5% | 13.0% | |
| Avg | 6.0% | 5.3% | 6.2% | |
| Low | 2.4% | 0.3% | 1.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.75 | 0.86 | 1.01 |
| Avg | 0.70 | 0.79 | 0.90 |
| Low | 0.67 | 0.70 | 0.78 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 314.2% | 23.2% | 27.5% |
| Avg | 288.4% | 13.6% | 13.9% |
| Low | 270.2% | -0.5% | -1.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.